Cargando…

Natural language processing of implantable cardioverter-defibrillator reports in hypertrophic cardiomyopathy: A paradigm for longitudinal device follow-up

BACKGROUND: The follow-up of implantable cardioverter-defibrillators (ICDs) generates large amounts of valuable structured and unstructured data embedded in device interrogation reports. OBJECTIVE: We aimed to build a natural language processing (NLP) model for automated capture of ICD-recorded even...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siontis, Konstantinos C., Bhopalwala, Huzefa, Dewaswala, Nakeya, Scott, Christopher G., Noseworthy, Peter A., Geske, Jeffrey B., Ommen, Steve R., Nishimura, Rick A., Ackerman, Michael J., Friedman, Paul A., Arruda-Olson, Adelaide M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562689/ https://www.ncbi.nlm.nih.gov/pubmed/34734207 http://dx.doi.org/10.1016/j.cvdhj.2021.05.005

Ejemplares similares

Conversion of left atrial volume to diameter for automated estimation of sudden cardiac death risk in hypertrophic cardiomyopathy
por: Bhopalwala, Huzefa, et al.
Publicado: (2020)

Natural language processing for identification of hypertrophic cardiomyopathy patients from cardiac magnetic resonance reports
por: Dewaswala, Nakeya, et al.
Publicado: (2022)

Tandem deep learning and logistic regression models to optimize hypertrophic cardiomyopathy detection in routine clinical practice
por: Maanja, Maren, et al.
Publicado: (2022)

Refractory Torsades de Pointes Due to Dofetilide Overdose
por: Crosby, James, et al.
Publicado: (2021)

Deep Neural Network for Cardiac Magnetic Resonance Image Segmentation
por: Chen, David, et al.
Publicado: (2022)

Predictors of Mortality for Patients with COVID-19 in the Rural Appalachian Region
por: Bhopalwala, Huzefa, et al.
Publicado: (2022)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population
por: Siontis, Konstantinos C., et al.
Publicado: (2014)

Sex, Survival, and Cardiomyopathy: Differences Between Men and Women With Hypertrophic Cardiomyopathy
por: Siontis, Konstantinos C., et al.
Publicado: (2019)

COVID-19 VERSUS IMMUNE CHECKPOINT INHIBITOR MYOCARDITIS: A CLINICAL DILEMMA
por: Dewaswala, Nakeya, et al.
Publicado: (2023)

Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic Cardiomyopathy
por: Goldstein, Sarah A., et al.
Publicado: (2023)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005)

High Prevalence of Cardiac Amyloidosis in Clinically Significant Aortic Stenosis: A Meta-Analysis
por: Arshad, Samiullah, et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
por: Weinstock, Jonathan, et al.
Publicado: (2016)

IMPACT OF COVID-19 VACCINATION AFTER ORTHOTOPIC HEART TRANSPLANTATION
por: Noor, Ahmed, et al.
Publicado: (2022)

In-Hospital Outcomes of Acute Ischemic Stroke in Patients With Hypertrophic Cardiomyopathy
por: Sun, Daokun, et al.
Publicado: (2022)

Surgical management of diastolic heart failure after septal myectomy for obstructive hypertrophic cardiomyopathy
por: Sun, Daokun, et al.
Publicado: (2021)

Anesthesia in a Child with Newly Diagnosed Hypertrophic Cardiomyopathy for Placement of Implantable Cardioverter Defibrillator
por: Kumar, Rajnish, et al.
Publicado: (2018)

Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy
por: Patlolla, Sri Harsha, et al.
Publicado: (2022)

Clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care
por: Garmany, Ramin, et al.
Publicado: (2023)

Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator
por: Park, Yae Min
Publicado: (2023)

Outcomes of Heart Failure in COVID-19 Patients: An Appalachian Experience
por: Bhopalwala, Huzefa, et al.
Publicado: (2022)

Association of Preoperative Sleep-Disordered Breathing With Functional Status After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy
por: Sun, Daokun, et al.
Publicado: (2022)

Wearable cardioverter-defibrillator as bridging to ICD in pediatric hypertrophic cardiomyopathy with myocardial bridging – a case report
por: Kurath-Koller, Stefan, et al.
Publicado: (2020)

Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention
por: Yazaki, Kyoichiro, et al.
Publicado: (2021)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
por: Malhotra, Rakesh, et al.
Publicado: (2017)

High-Risk Apical Hypertrophic Cardiomyopathy Requiring an Implantable Cardioverter-Defibrillator: A Case Report of an Overlooked Etiology
por: Rathore, Azeem, et al.
Publicado: (2023)

Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
por: Liang, Jin-Jun, et al.
Publicado: (2019)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Obstetric hemorrhage in a case of hypertrophic obstructive cardiomyopathy with automatic implantable cardioverter defibrillator: Anaesthesia and intensive care management
por: Mishra, Sandeep Kumar, et al.
Publicado: (2016)

Atrial fibrillation deteriorates tricuspid regurgitation following implantable cardioverter defibrillator lead placement in patient with hypertrophic obstructive cardiomyopathy
por: Mohri, Takato, et al.
Publicado: (2017)

Progressive electrical remodeling in apical hypertrophic cardiomyopathy leading to implantable cardioverter-defibrillator sensing failure during ventricular fibrillation
por: Fleeman, Blake E., et al.
Publicado: (2016)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Shoulder Joint Dislocation as an Unusual Complication of Defibrillation Threshold Testing Following Subcutaneous Implantable Cardioverter-Defibrillator Implantation
por: Noheria, Amit, et al.
Publicado: (2014)

Cardiac Troponin-I and COVID-19: A Prognostic Tool for In-Hospital Mortality
por: AL Abbasi, Baher, et al.
Publicado: (2020)

Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy
por: Sugrue, Alan, et al.
Publicado: (2017)

A Pregnancy with Severe Hypertrophic Obstructive Cardiomyopathy after Surgery for an Implantable Cardioverter Defibrillator: A Case Report and Literature Review
por: Mitsui, Takashi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qs7i2rl0j6rl8n2001orbce3sk